Confocal Laser Microscopy in Non Erosive Reflux Disease
Study Details
Study Description
Brief Summary
Heartburn or reflux disease affects about 20% of Americans. 50 - 70% of people who have endoscopy for reflux disease have a normal appearing esophagus. Confocal Laser Microscopy allows us to see changes in the cells not visable during routine endoscopy. Whe goal of this study is to identify the use of this new technique in diagnosing reflux in patients who have normal appearing esophagus.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Gastroesophageal reflux disease (GERD) remains a major problem in the United States affecting about 20% of Americans. Upper endoscopy (EGD) is commonly used to diagnose and grade GERD based on mucosal breaks and erosions. It is now evident from multiple studies however that the majority of GERD patients (50-70%) have negative EGDs.These patients are refered to as "Non Erosive Reflux Disease" (NERD) patients.Confocal Laser Microscopy (CLM) is a new endoscopic technique that offers the advantage of detecting histologic changes during real time endoscopy and thus can diagnose NERD. We thus propose to study the sensitivity and specificity of CLM in predicting NERD. We hypothesize that CLM can reliably diagnose NERD in the appropriate clinical setting based on intrapapillary capillary loop patterns. This will be a pilot study after which a randomized trial will evaluate the reversibility of these changes after PPI therapy as seen by CLM
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
I participants with symptoms of acid reflux disease (heartburn) |
Device: Cell~vizio (Laser connfocal microscopy)
completed during endoscopy
Other Names:
|
Outcome Measures
Primary Outcome Measures
- To assess the sensitivity, specificity, negative and positive predictive value of CLM in diagnosing NERD [at time of procedure]
Secondary Outcome Measures
- To assess the additional charges of implementing CLM in EGD [at time of procedure]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients 18 years to 85 years old who are referred for an upper endoscopy for symptoms of reflux disease
-
Patients who are able to give informed consent
Exclusion Criteria:
-
Patients with a history of Erosive esophagitis
-
Patients with a history of Barrett's esophagus
-
Patients who on upper endoscopy have any current evidence of erosive esophagitis, Barrett's esophagus or varices
-
Patients who are unable or unwilling to undergo endoscopic evaluation
-
Patients who are unable to give informed consent
-
Patients with a known coagulopathy who are unable to be off therapy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mayo Clinic | Rochester | Minnesota | United States | 55901 |
Sponsors and Collaborators
- Mayo Clinic
Investigators
- Study Director: Kenneth K Wang, MD, Mayo Clinic
- Principal Investigator: Rami Badreddine, MD, Malyo Clinic Rochester
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 07-006186